Arthritis & Rheumatic Disease Specialties is categorized under Doctors in Miami, FL and active since 2008.
Arthritis & Rheumatic Disease Specialties was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Norman B Gaylis at the company’s single location by writing to 21097 Ne 27th Court, Miami, Florida FL 33180 or by phoning (305) 652-6676. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Arthritis & Rheumatic Disease Specialties |
Contact Person: | Norman B Gaylis |
Address: | 21097 Ne 27th Court, Miami, Florida 33180 |
Phone Number: | (305) 652-6676 |
Website Address: | rheum-care.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Arthritis & Rheumatic Disease Specialties was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Norman B Gaylis for inquiries that concern Arthritis & Rheumatic Disease Specialties by calling the company number (305) 652-6676, as your correspondence is most welcome. Additionally, the physical location of the single location of Arthritis & Rheumatic Disease Specialties can be found at the coordinates 25.970648,-80.146502 as well as the street address 21097 Ne 27th Court in Miami, Florida 33180.
For its online presence, you may visit Arthritis & Rheumatic Disease Specialties’s website at rheum-care.com and engage with its social media outlets through on Twitter and on Facebook.